
Inorganic Chemistry Communications p. 39 - 44 (2014)
Update date:2022-08-18
Topics:
Farsani, Mostafa Riahi
Yadollahi, Bahram
Rudbari, Hadi Amiri
Amini, Akbar
Caradoc-Davis, Tom
Price, Jason R.
A stable sandwich type Keggin polyoxometalate, Na4K 5[K3Cu3(NO3)(A-α-PW 9O34)2], has been synthesized and crystallized by a simple reaction method. Elemental analysis, FTIR, UV-vis, X-ray single crystal, thermal gravimetry, and cyclic voltammetry were used for the characterization of synthesized POM. The TBA salt of [K3Cu 3(PW9O34)2]9 - revealed high catalytic activity and 74-99% selectivity in the liquid phase epoxidation of alkenes with aqueous H2O2. The X-ray structure of this complex reveals that three Cu(II) ions are sandwiched between two A-α-PW9O34 moieties and that a nitrate monoanion is encapsulated in the same plane as the three Cu(II) atoms. The nitrate is coplanar with the three copper atoms, which are each in a distorted square-pyramidal environment. After recrystallization, the NO3 - group in the central belt didn't exit, in which this phenomenon is attributed to the type of counterion in the complex (as a result of mixing Na+ and K+ as counterions). This compound showed excellent stability in different pH and also didn't dissociate with hydrogen peroxide.
View More
Changzhou Sunlight Pharmaceutical Co., Ltd.
Contact:+86-519-83131668;83139028;83138042;83137041
Address:JiuliStreet, Benniu Town Changzhou City, Jiangsu Province
website:http://www.konochem.com
Contact:86-29-86107037
Address:No.170 West Avenue,Xi’an 710082,China
Jingzhou TianHe Sci&Tech Chemical Co., Ltd.
Contact:86-716-8331612
Address:Jiangjin Road, #18, High-grade technology industries development district, Jingzhou city, Hubei province
Heliosense Biotechnologies, Inc.
website:https://www.heliosense.com/
Contact:+86-592-5667290
Address:Xiamen Torch Hi-tech Zone Venture Weiye Building S506
Contact:+86-21-6856-1349 523-87676172
Address:No16 . BinJiang Road . Taixing Economy Developing Area .JiangSu Province . China
Doi:10.1007/BF02496133
(1997)Doi:10.3389/fimmu.2019.02969
(2020)Doi:10.1002/zaac.201400506
(2015)Doi:10.1021/ol060755w
(2006)Doi:10.1016/j.ijpharm.2014.03.011
(2014)Doi:10.1039/d0ra01816c
(2020)